The latest update on Snowflake comes with a lower fair value estimate, moving from US$282.90 to US$236.61, roughly a 16% cut ...
Tilray shares rally as Trump urges the DOJ to quickly reclassify cannabis as a Schedule III drug. Options pricing suggests ...